New era of “AD prevention and treatment” officially sets sail
On March 31, the first seminar on case studies of IMR blood tests for AD was co-hosted by MMB-Innovative biotechnology limited, Kindstar Global Medicine Technology - the leader of domestic hematology testing center - and the domestic famous pharmaceutical company ARK PHA. Ltd.
MMB-Innovative biotechnology limited introduced the only IMR AD blood test product which passed the most rigorous clinical trials worldwide. Namely the first magnetic deaturometer in China has also officially set sail. After heated discussions with several famous domestic experts and the first step of scientific research cooperation for more than four months, the research findings were highly evaluated by all participating experts, and the academic conference on the important results of this research was held as a result.
IMR inventor - Professor Yang Xile
Professor Yang Xile, the inventor of the IMR, introduced the application value and direction of IMR in blood testing during the meeting.
The results of this scientific cooperation received considerable attention from Professor Jia Jianping team from Xuanwu Hospital, Professor Wang Yanjiang from Chongqing Daping Hospital, Director Liu Xiaolei from the First Affiliated Hospital of Kunming Medical University, Professor Xie Haiqun of the First People’s Hospital of Foshan, Professor Li Xia of Shanghai Mental Health Center, and Professor Liu Jun of Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University and dozens of doctors and experts from all provinces, and has stimulated enthusiastic response from experts from all over the country.
Professor Xie Haiqun, the First People’s Hospital of Foshan
According to Rao Xiaosong, president of MMB-Innovative biotechnology limited, the results of scientific research have been highly consistent with the result of scientific research and clinical diagnosis in the United States, Japan, and European countries. The research team of Professor Xie Haiqun, Professor Wang Yanjiang and Professor Liu Jun shared and highly evaluated the application of IMR in the clinic cases, and mentioned the significance and value that product and technology may bring in the clinical applications.
After the meeting, the participants and testing experts expect that the IMR AD blood test introduced by MMB-Innovative biotechnology limited officially started in China. Kindstar Global has introduced the technology, and hopes to benefit the patients, and improves the prevention and treatment of this disease!
On March 31, the first seminar on case studies of IMR blood tests for AD was co-hosted by MMB-Innovative biotechnology limited, Kindstar Global Medicine Technology - the leader of domestic hematology testing center and the domestic famous pharmaceutical company ARK PHA. Ltd.